...
首页> 外文期刊>American Journal of Cancer Research >SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer
【24h】

SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer

机译:SHCBP1调节STAT3 / C-MYC信号传导激活,以促进肿瘤癌症的肿瘤进展

获取原文
           

摘要

A challenge in developing novel strategies for penile cancer (PC) is the limited understanding of the regulatory mechanisms involved in PC development. This study aims to examine the expression of SHC SH2 Domain-Binding Protein 1 (SHCBP1) in PC and to explore its oncogenic function. Aberrant SHCBP1 expression was observed in PC tissues compared with normal penile tissues. SHCBP1 expression was significantly associated with the pathological grade, T stage, nodal status, and pelvic lymph node metastasis, and could serve as an independent factor for unfavorable overall survival in PC. Manipulation of SHCBP1 expression affected cell proliferation, soft agar clonogenesis, and cell migration and invasion in PC cell lines. Moreover, we identified STAT3/c-Myc signaling as a potential downstream target of SHCBP1. SHCBP1 interacted with JAK2 and STAT3 upon EGF stimulation, which might regulate STAT3/c-Myc signaling activation in PC cells. Disruption of STAT3/c-Myc signaling attenuated cell proliferation and cell migration/invasion in PC cell lines. Nevertheless, overexpression of constitutively activated STAT3 or c-Myc rescued cell proliferation and cell migration/invasion caused by SHCBP1 depletion in PC cell lines. Consistently, SHCBP1 depletion attenuated STAT3/c-Myc signaling and suppressed tumor growth in a murine xenograft model. Importantly, correlated expression of SHCBP1, p-STAT3, and c-Myc was observed in PC tissues, confirming the clinical relevance of SHCBP1/STAT3/c-Myc signaling in PC. In conclusion, aberrant SHCBP1 expression could serve as a potential prognostic biomarker for PC. SHCBP1 might activate the STAT3/c-Myc signaling pathway to promote tumor progression in PC, which may serve as a potential target for PC treatment.
机译:开发新型阴茎癌战略(PC)的挑战是对涉及PC开发的监管机制的有限理解。本研究旨在检测PC中SHC SH2结构域结合蛋白1(SHCBP1)的表达并探讨其致癌功能。与正常阴茎组织相比,在PC组织中观察到异常SHCBP1表达。 SHCBP1表达与病理级,T阶段,节点状态和盆腔淋巴结转移显着相关,并且可以作为PC中不利整体生存的独立因素。 ShCBP1表达的操纵影响了PC细胞系中的细胞增殖,软琼脂克隆发生和细胞迁移和侵袭。此外,我们将STAT3 / C-MYC信令标识为SHCBP1的潜在下游目标。 SHCBP1在EGF刺激时与JAK2和Stat3相互作用,这可能会调节PC细胞中的STAT3 / C-MYC信号传导激活。 STAT3 / C-MYC信号传导衰减细胞增殖和PC细胞系细胞迁移/侵袭的破坏。然而,由PC细胞系中的SHCBP1耗竭引起的组成型活化的STAT3或C-MYC救出的细胞增殖和细胞迁移/侵袭的过表达。始终如一地,SHCBP1耗竭衰减STAT3 / C-MYC信号传导和抑制鼠异叶移植模型中的肿瘤生长。重要的是,在PC组织中观察到SHCBP1,P-STAT3和C-MYC的相关表达,确认SHCBP1 / Stat3 / C-MYC信号传导在PC中的临床相关性。总之,异常的SHCBP1表达可以用作PC的潜在预后生物标志物。 SHCBP1可能激活STAT3 / C-MYC信号通路,以促进PC中的肿瘤进展,这可以作为PC治疗的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号